Short answer
A US supplement brand entering the EU moves from DSHEA to EU food law, and four things usually have to change: an EU-based responsible operator (often the importer) must stand behind the product, every ingredient and nutrient form must be allowed in the EU, US structure/function claims must be replaced with authorised EU health claims, and the label must be rebuilt in the local language and filed in each country that requires a notification. FDA facility registration and the FDA disclaimer carry no legal weight in the EU.
DSHEA vs EU food law: what actually changes
Both systems treat supplements as a category of food rather than drugs, and neither runs a general pre-market approval for finished products. The FDA states that "Under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed" (FDA, Questions and Answers on Dietary Supplements). In the EU, a food supplement is likewise placed on the market under the operator's responsibility. The similarity ends there.
| Topic | United States | European Union |
|---|---|---|
| Core law | DSHEA, part of the Federal Food, Drug, and Cosmetic Act | Directive 2002/46/EC plus general EU food law (Regulations 178/2002, 1169/2011, 1924/2006, 2015/2283) |
| Who is responsible | Manufacturer, packer or distributor named on the label | The EU operator under whose name the food is marketed, or the EU importer if that operator is outside the Union |
| New ingredients | New dietary ingredient notification at least 75 days before marketing | Novel food authorisation and listing before any use |
| Cut-off date | Marketed in the US before 15 October 1994 | Consumed to a significant degree in the EU before 15 May 1997 |
| Vitamin and mineral forms | Broad | Only forms listed in Annex II of Directive 2002/46/EC |
| Claims | Structure/function claims with the FDA disclaimer | Only authorised claims from the EU register, with their conditions of use |
| Manufacturing | cGMP under 21 CFR Part 111 | Food hygiene and HACCP-based procedures under Regulation 852/2004 |
| Market entry filing | None for the finished product (facility registration aside) | National notification in each member state that requires it |
You need an EU responsible operator
Regulation (EU) No 1169/2011, Article 8(1), makes the responsible food business operator the one "under whose name or business name the food is marketed", or "if that operator is not established in the Union, the importer into the Union market." That operator also carries the general duty in Article 17(1) of Regulation (EC) No 178/2002 to ensure that the food satisfies food law and to "verify that such requirements are met."
So a US LLC cannot simply ship to EU consumers and treat compliance as someone else's problem. The realistic options are an EU subsidiary, an EU importer or distributor acting as operator, or an EU entity that you control and that is named on the label. The choice decides who files notifications, who answers the authorities and who owns the market data. We compare these structures in importing supplements from the UK and US to Poland and new supplement brands in Poland for foreign companies.
Ingredients: NDI is not novel food
A US "new dietary ingredient" is "a dietary ingredient that was not marketed in the United States before October 15, 1994", and the notification must reach FDA "at least 75 days before being introduced or delivered for introduction into interstate commerce" (21 U.S.C. 350b). An ingredient that is old in the US can still be new in Europe. Under Article 3(2)(a) of Regulation (EU) 2015/2283, a novel food is food "that was not used for human consumption to a significant degree within the Union before 15 May 1997", and under Article 6(2) "Only novel foods authorised and included in the Union list may be placed on the market".
Two practical consequences:
- Run every ingredient through the EU Novel Food Catalogue, including extracts, specific forms and ingredients obtained by new processes. A US NDI acknowledgement or GRAS status does not answer the EU question.
- Check vitamin and mineral forms against Annex II. Article 4(1) of Directive 2002/46/EC: "Only vitamins and minerals listed in Annex I, in the forms listed in Annex II, may be used". Chelates and branded forms common in US formulas need to be matched to a listed form.
Doses: US levels often travel badly
The EU has no harmonised maximum levels for vitamins and minerals in supplements yet. The European Commission notes that "no proposal has yet been presented due to the complex nature of the issue and the divergent views that were expressed" (European Commission). National authorities fill the gap with their own reference values and practice. A daily dose that is routine on a US shelf can trigger questions in a member state such as Poland, where the sanitary inspection can open explanatory proceedings after a notification. See our guide to novel food and maximum doses in Poland before deciding whether to keep the US dose or build an EU SKU.
Claims: the FDA disclaimer does not exist in the EU
In the US, a structure/function claim is paired with the disclaimer set out in 21 CFR 101.93(c): "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." (eCFR, 21 CFR 101.93). There is no EU equivalent and adding it does not make an unauthorised claim legal.
In the EU a health claim is "any claim that states, suggests or implies that a relationship exists between a food category, a food or one of its constituents and health" (Article 2(2)(5) of Regulation (EC) No 1924/2006), and Article 10(1) states that "Health claims shall be prohibited unless" they are authorised and included in the EU lists. That covers website copy, Amazon bullet points and influencer briefs, not only the pack. Rebuild claims from the EU Register of nutrition and health claims and read our health claims guide.
Label: Supplement Facts becomes an EU label
The US Supplement Facts panel cannot be stickered over and called compliant. The EU label must carry the particulars in Article 9(1) of Regulation 1169/2011, including "the name or business name and address of the food business operator referred to in Article 8(1)", and the supplement-specific items in Article 6(3) of Directive 2002/46/EC, such as "the portion of the product recommended for daily consumption" and "a warning not to exceed the stated recommended daily dose". Article 15(1) requires the mandatory information "in a language easily understood by the consumers of the Member States where a food is marketed".
Decide early between a dedicated EU pack and relabelling US stock. Relabelling is legal when done properly, but it fixes only the label, not the formula. See relabelling supplements for Poland and the Polish label checklist.
Manufacturing: cGMP is a good start, not a substitute
US manufacturers work under the cGMP rules in 21 CFR Part 111, and FDA requires that "Facilities that manufacture, process, pack, or hold dietary supplements or dietary ingredients" "must register with FDA". None of that is an EU registration. In the EU, hygiene rules in Regulation (EC) No 852/2004 require HACCP-based procedures (Article 5(1)) and the registration of each establishment with the competent authority (Article 6(2)). If you keep US manufacturing, the EU importer still needs the specifications, certificates of analysis and supplier data to meet traceability duties: operators "shall be able to identify any person from whom they have been supplied with a food" (Article 18(2), Regulation 178/2002).
Many US brands end up producing EU stock with an EU contract manufacturer to shorten lead times and simplify import. Compare options in supplement contract manufacturers in Poland.
A realistic entry route for a US brand
- Pick one first market.Notification and dose practice are national. Start where your category is large and measurable. For Poland, see is Poland right for your brand.
- Set up the EU operator.Subsidiary, importer or distributor - in writing, including who owns notifications.
- Screen the formula.Novel food status, Annex II forms, doses, botanical identity.
- Rebuild claims and label.EU register claims only, local language, all mandatory particulars.
- Decide manufacturing.Import from the US or produce in the EU.
- Notify.In Poland, electronically to the Chief Sanitary Inspector before the first sale - see supplement registration in Poland.
- Launch in one channel first.Marketplaces such as Allegro are a fast test - see selling supplements on Allegro.
US SKU to EU SKU checklist
| Check | Question to answer | Status |
|---|---|---|
| Operator | Which EU entity is named on the label? | Decided / open |
| Novel food | Is every ingredient non-novel or authorised in the Union list? | Cleared / to review |
| Nutrient forms | Is every vitamin and mineral form in Annex II? | Cleared / to review |
| Doses | Are doses in line with the first market's practice? | Cleared / to review |
| Claims | Is every claim on pack and online in the EU register? | Verified / to review |
| Label | All mandatory particulars in the local language? | Final / draft |
| Product file | Specifications, CoAs, supplier data for traceability? | Complete / gaps |
| Notification | Filed before the first sale in each country? | Filed / pending |
Sources
Primary legal texts and official pages used in this guide. Always read the consolidated version in force on the day you act.
- Directive 2002/46/EC on food supplements
- Regulation (EC) No 178/2002 - General Food Law
- Regulation (EU) No 1169/2011 - food information to consumers
- Regulation (EC) No 1924/2006 - nutrition and health claims
- Regulation (EU) 2015/2283 - novel foods
- Regulation (EC) No 852/2004 - hygiene of foodstuffs
- European Commission - food supplements
- EU Register of nutrition and health claims
- EU Novel Food Catalogue
- FDA - Questions and Answers on Dietary Supplements
- 21 U.S.C. 350b - new dietary ingredients
- 21 CFR 101.93 - structure/function claims disclaimer
- 21 CFR Part 111 - cGMP for dietary supplements